A novel mutation of keratin 9 in epidermolytic palmoplantar keratoderma combined with knuckle pads

American Journal of Medical Genetics

Volumn 120 A, Issue 3, 2003, Pages 345-349

  Lu, Yong ^a   Guo, Chenhong ^a   Liu, Qiji ^a   Zhang, Xiyu ^a   Cheng, Lin ^a   Li, Jiangxia ^a   Chen, Bingxi ^a   Gao, Guimin ^a   Zhou, Haibin ^a   Guo, Yishou ^a   Li, Yefu ^b   Gong, Yaoqin ^a  

^a SHANDONG UNIVERSITY   (China)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Epidermolytic palmoplantar keratoderma; Keratin 9; Knuckle pads; KRT9; Mutation

Indexed keywords

KERATIN; KERATIN 9; UNCLASSIFIED DRUG;

ARTICLE; AUTOSOMAL DOMINANT DISORDER; CHINA; CLINICAL ARTICLE; EPIDERMOLYTIC PALMOPLANTAR KERATODERMA; GENETIC ANALYSIS; HUMAN; HYPERKERATOSIS; KERATOSIS PALMOPLANTARIS; LINKAGE ANALYSIS; MUTATION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECONDARY STRUCTURE;

EID: 0041413308     PISSN: 15524825     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajmg.a.20090     Document Type: Article

References (27)

1. Bonifas JM, Bare JW, Chen MA, Lee MK, Slater CA, Goldsmith LA, Epstein EH. 1992. Linkage of the epidermolytic hyperkeratosis phenotype and the region of the type II keratin gene cluster on chromosome 12. J Invest Dermatol 99(5):524-527.
2. Bonifas JM, Matsumura K, Chen MA, Berth-Jones J, Hutchison PE, Zloczower M, Fritsch PO, Epstein EH, Jr. 1994. Mutations of keratin 9 in two families with palmoplantar epidermolytic hyperkeratosis. J Invest Dermatol 103(4):474-477.
3. Coleman CM, Munro CS, Smith FJ, Uitto J, McLean WH. 1999. Epidermolytic palmoplantar keratoderma due to a novel type of keratin mutation, a 3-bp insertion in the keratin 9 helix termination motif. Br J Dermatol 140(3):486-490.
4. Coulombe PA, Fuchs E. 1990. Elucidating the early stages of keratin filament assembly. J Cell Biol 111(1):153-169.
5. Covello SP, Irvine AD, McKenna KE, Munro CS, Nevin NC, Smith FJ, Uitto J, McLean WH. 1998. Mutations in keratin K9 in kindreds with epidermolytic palmoplantar keratoderma and epidemiology in Northern Ireland. J Invest Dermatol 111(6):1207-1209.
6. Endo H, Hatamochi A, Shinkai H. 1997. A novel mutation of a leucine residue in coil 1A of keratin 9 in epidermolytic palmoplantar keratoderma. J Invest Dermatol 109(1):113-115.
7. Expasy: http://www.expasy.ch/cgi-bin/niceprot.pl?P35527
8. Gibrat JF, Garnier J, Robson B. 1987. Further developments of protein secondary structure prediction using information theory. New parameters and consideration of residue pairs. Mol Biol 198(3):425-443.
9. Hanukoglu I, Fuchs E. 1983. The cDNA sequence of a Type II cytoskeletal keratin reveals constant and variable structural domains among keratins. Cell 33(3):915-924.
10. Heald R, McKeon F. 1990. Mutations of phosphorylation sites in lamin A that prevent nuclear lamina disassembly in mitosis. Cell 18 61(4):579-589.
11. Hennies HC, Zehender D, Kunze J, Kuster W, Reis A. 1994. Keratin 9 gene mutational heterogeneity in patients with epidermolytic palmoplantar keratoderma. Hum Genet 93(6):649-654.
12. Knapp AC, Franke WW, Heid H, Hatzfeld M, Jorcano JL, Moll R. 1986. Cytokeratin No. 9, an epidermal type I keratin characteristic ofa special program of keratinocyte differentiation displaying body site specificity. J Cell Biol 103(2):657-667.
13. Kobayashi S, Kore-eda S, Tanaka T. 1999. Demonstration of the pathogenic effect of point mutated keratin 9 in vivo. FEBS Lett 19 447(1):39-43.
14. Langbein L, Heid HW, Moll I, Franke WW. 1993. Molecular characterization of the body site-specific human epidermal cytokeratin 9: cDNA cloning, amino acid sequence, and tissue specificity of gene expression. Differentiation 55:57-72.
15. Lathrop GM. 1983. Estimating genotype relative risks. Tissue Antigens 22(2):160-166.
16. Lessin SR, Huebner K, Isobe M, Croce CM, Steinert PM. 1988. Chromosomal mapping of human keratin genes: Evidence of non-linkage. J Invest Dermatol 91(6):572-578.
17. Parry DA, Crewther WG, Fraser RD, MacRae TP. 1977. Structure of alpha-keratin: Structural implication of the amino acid sequences of the type I and type II chain segments. J Mol Biol 113(2):449-454.
18. Reis A, Kuster W, Eckardt R, Sperling K. 1992. Mapping of a gene for epidermolytic palmoplantar keratoderma to the region of the acidic keratin gene cluster at 17q12-q21. Hum Genet 90:113-116.
19. Reis A, Hennies HC, Langbein L, Digweed M, Mischke D, Drechsler M, Schrock E, Royer-Pokora B, Franke WW, Sperling K, et al. 1994. Keratin 9 gene mutations in epidermolytic palmoplantar keratoderma (EPPK). Nat Genet 6(2):174-179.
20. Rosenberg M, RayChaudhury A, Shows TB, Le Beau MM, Fuchs E. 1988. A group of type I keratin genes on human chromosome 17: Characterization and expression. Mol Cell Biol 8(2):722-736.
21. Rothnagel JA, Wojcik S, Liefer KM, Dominey AM, Huber M, Hohl D, Roop DR. 1995. Mutations in the 1A domain of keratin 9 in patients with epidermolytic palmoplantar keratoderma. J Invest Dermatol 104(3): 430-433.
22. Steinert PM. 1990. The two-chain coiled-coil molecule of native epidermal keratin intermediate filaments is a type I-type II heterodimer. J Biol Chem 265(15):8766-8774.
23. Steinert PM. 1993. Structure, function, and dynamics of keratin intermediate filaments. Invest Dermatol 100(6):729-734.
24. Steinert PM, Idler WW, Zhou XM, Johnson LD, Parry DA, Steven AC, Roop DR. 1985. Structural and functional implications of amino acid sequences of keratin intermediate filament subunits. Ann NY Acad Sci 455:451-461.
25. Steinert PM, Marekov LN, Fraser RD, Parry DA. 1993a. Keratin intermediate filament structure. Crosslinking studies yield quantitative information on molecular dimensions and mechanism of assembly. Mol Biol 230(2):436-452.
26. Steinert PM, Yang JM, Bale SJ, Compton JG. 1993b. Concurrence between the molecular overlap regions in keratin intermediate filaments and the locations of keratin mutations in genodermatoses. Biochem Biophys Res Commun 197(2):840-848.
27. Torchard D, Blanchet-Bardon C, Serova O, Langbein L, Narod S, Janin N, Goguel AF, Bernheim A, Franke WW, Lenoir GM. 1994. Epidermolytic palmoplantar keratoderma cosegregates with a keratin 9 mutation in a pedigree with breast and ovarian cancer. Nat Genet 6(1):106-110.